Saturday 17 October 2026 Export PACB’s income statement to Excel — free account

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $160.0 million, up 3.89% from fiscal 2024. In the quarter to June 2026, revenue fell 1.91%, EPS was flat, free cash flow fell 31.0% and total debt was flat, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

1.73 0.23 −11.73%

Follow PACB

Alert me

Market cap: $609.2M
P/E: 0.0×
Fwd P/E: −3.5×
Dividend yield: —
F-score: 3/9
Altman Z: −6.04
Beneish M: −5.14
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Pacific Biosciences of California, Inc. (PACB) P/E ratio

Alert me on P/E ratio

Pacific Biosciences of California, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 426× (February 2021) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PACB/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Pacific Biosciences of California, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PACB/metrics/pe-ratio">Pacific Biosciences of California, Inc. (PACB) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	216×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
Sep 2025	0.0×	—
42 more quarters	Free account

Against its own ten years

Low 0.0× High 426×

Ten-year median 0.0×

Current reading's percentile 98

Company	P/E ratio
SSII SS Innovations International, Inc. compare	n/m
SGHT Sight Sciences, Inc. compare	n/m
PACB Pacific Biosciences of California, Inc.	n/m
CTKB Cytek Biosciences, Inc. compare	n/m
KIDS OrthoPediatrics Corp. compare	n/m
MASS 908 Devices Inc. compare	n/m
TCMD Tactile Systems Technology, Inc. compare	20.5×
BWAY Brainsway Ltd. Sponsored ADR compare	24.8×
DCTH Delcath Systems, Inc. compare	1,408×
Medical Devices industry median	23.2×
Healthcare sector median	23.0×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Pacific Biosciences of California, Inc. (PACB) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PACB

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on PACB

Stockrow Weekly